BRPI0716404A2 - aplicaÇço transdermal de triazinas para o combate de infecÇÕes por coccÍdeos - Google Patents

aplicaÇço transdermal de triazinas para o combate de infecÇÕes por coccÍdeos

Info

Publication number
BRPI0716404A2
BRPI0716404A2 BRPI0716404-1A2A BRPI0716404A BRPI0716404A2 BR PI0716404 A2 BRPI0716404 A2 BR PI0716404A2 BR PI0716404 A BRPI0716404 A BR PI0716404A BR PI0716404 A2 BRPI0716404 A2 BR PI0716404A2
Authority
BR
Brazil
Prior art keywords
triazines
combat
transdermal application
coccidial infections
coccidial
Prior art date
Application number
BRPI0716404-1A2A
Other languages
English (en)
Inventor
Iris Heep
Hans-Christian Mundt
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of BRPI0716404A2 publication Critical patent/BRPI0716404A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0716404-1A2A 2006-08-16 2007-08-08 aplicaÇço transdermal de triazinas para o combate de infecÇÕes por coccÍdeos BRPI0716404A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006038292A DE102006038292A1 (de) 2006-08-16 2006-08-16 Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
PCT/EP2007/006992 WO2008019785A2 (de) 2006-08-16 2007-08-08 Transdermale anwendung von triazinen zur bekämpfung von coccidien-infektionen

Publications (1)

Publication Number Publication Date
BRPI0716404A2 true BRPI0716404A2 (pt) 2013-09-17

Family

ID=38670715

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716404-1A2A BRPI0716404A2 (pt) 2006-08-16 2007-08-08 aplicaÇço transdermal de triazinas para o combate de infecÇÕes por coccÍdeos

Country Status (22)

Country Link
US (1) US20100179151A1 (pt)
EP (1) EP2054064A2 (pt)
JP (1) JP5340936B2 (pt)
KR (1) KR101489763B1 (pt)
CN (1) CN101505756A (pt)
AU (1) AU2007286507B2 (pt)
BR (1) BRPI0716404A2 (pt)
CA (1) CA2660762C (pt)
CO (1) CO6150133A2 (pt)
CR (1) CR10618A (pt)
DE (1) DE102006038292A1 (pt)
GT (1) GT200900031A (pt)
IL (1) IL196864A (pt)
MX (1) MX2009001516A (pt)
MY (1) MY151858A (pt)
NI (1) NI200900017A (pt)
NZ (1) NZ574885A (pt)
RU (1) RU2484825C9 (pt)
SV (1) SV2009003169A (pt)
UA (1) UA98117C2 (pt)
WO (1) WO2008019785A2 (pt)
ZA (1) ZA200900913B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
BR112014032632A2 (pt) 2012-06-27 2017-06-27 Kemin Ind Inc composições e método para controle de coccidiose em animais, e, método para reduzir a atividade de esporozoítos em um animal.
US10568923B2 (en) 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
MX2020008816A (es) 2018-02-26 2020-09-28 AlzeCure Pharma AB Derivados de triazina para el tratamiento de enfermedades relacionadas con neurotrofinas.
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
NO344832B1 (no) * 2018-11-02 2020-05-18 Inakva As Sammensetning for anvendelse i hindring eller behandling av angrep eller infeksjon av parasitter på fisk

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853388A (en) * 1987-05-15 1989-08-01 Pearlman Dale L Method for treating psoriasis with cytotoxic agents
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
ATE277596T1 (de) * 1997-02-24 2004-10-15 Sla Pharma Ag Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
CA2213385A1 (en) * 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
AU766542B2 (en) * 1998-10-08 2003-10-16 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
RU2174834C1 (ru) * 2000-05-18 2001-10-20 Открытое акционерное общество завод "Ветеринарные препараты" Препарат для профилактики и лечения кокцидиоза птиц
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
US20050058695A1 (en) * 2002-05-30 2005-03-17 Watson Pharmaccuticals, Inc. Norethindrone sustained release formulations and methods associated therewith
BRPI0406795A (pt) * 2003-01-16 2006-01-17 Janssen Pharmaceutica Nv Composições antiprotozoários que compreendem diclazuril
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren

Also Published As

Publication number Publication date
CO6150133A2 (es) 2010-04-20
SV2009003169A (es) 2009-07-28
ZA200900913B (en) 2010-04-28
MX2009001516A (es) 2009-02-18
KR101489763B1 (ko) 2015-02-05
JP5340936B2 (ja) 2013-11-13
GT200900031A (es) 2010-10-04
IL196864A0 (en) 2009-11-18
WO2008019785A2 (de) 2008-02-21
CA2660762A1 (en) 2008-02-21
IL196864A (en) 2016-06-30
DE102006038292A1 (de) 2008-02-21
NI200900017A (es) 2010-04-19
AU2007286507B2 (en) 2013-02-21
NZ574885A (en) 2012-03-30
UA98117C2 (uk) 2012-04-25
WO2008019785A3 (de) 2008-10-16
RU2484825C9 (ru) 2013-11-20
CR10618A (es) 2009-07-07
AU2007286507A1 (en) 2008-02-21
MY151858A (en) 2014-07-14
JP2010500385A (ja) 2010-01-07
EP2054064A2 (de) 2009-05-06
CN101505756A (zh) 2009-08-12
RU2009109159A (ru) 2010-09-27
US20100179151A1 (en) 2010-07-15
RU2484825C2 (ru) 2013-06-20
KR20090047520A (ko) 2009-05-12
CA2660762C (en) 2015-02-10

Similar Documents

Publication Publication Date Title
BRPI0716404A2 (pt) aplicaÇço transdermal de triazinas para o combate de infecÇÕes por coccÍdeos
CY2019044I1 (el) Αναστολεις διυδροπυριδοφθαλαζινονης της πολυμερασης της πολυαδενοσφωσφορικης ριβοζης (parp)
BRPI0807487A2 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
BRPI0820153A2 (pt) Aperfeiçoamento de ação direta para rifles
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
PT2613774T (pt) Combinação de fenoxibenzamina e polimixina e para tratar infeções microbianas
BRPI0920122A2 (pt) Uso de ditiin-tetracarboximidas para combater fungos fitopatogênicos
BRPI0807541A2 (pt) Controle de propriedades de transporte para e de superfícies de nanopartícula
BRPI0812206A2 (pt) Métodos para melhorar o desempenho de proteínas
PT2280973E (pt) Análogos de carba-nucleósido para tratamento antiviral
DK2087307T3 (da) Med afstand anbragt letvægtskompositpanser
BRPI0719174A2 (pt) preparação de pirimidinas ribofuranosil nucleosídeos
BRPI0807222A2 (pt) Análogos de neucleosídeo para tratamento de infecções virais
BRPI0817473A2 (pt) plataforma de aplicativo para executar aplicativos
BRPI0718548A2 (pt) Estabilização de vacinas por liofilização
EP2036552A4 (en) SENESCENCE INHIBITOR
BRPI0820565A2 (pt) Métodos para aumentar o teor de amido em plantas
BRPI0810287A2 (pt) "elemento natural de aeronave"
FR2908130B1 (fr) Flottage de vitroceramique
BRPI0715728A2 (pt) tratamento de distérbio cartilaginosos
BRPI0813760A2 (pt) Instalação para defesa ou proteção com liberação de controle para entrada de pessoas
EP2328757A4 (en) BEAM PERFORMANCE
EP2242714A4 (en) Protective insert
BRPI0814115A2 (pt) Composição farmacêutica compreendendo composto de 11-deóxi-prostaglandina e método para estabilizar o composto
BRPI0815144A2 (pt) Método para separar e purificar um composto de amina alfa-insaturado

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]